glutathione s transferase reaction with benzopyrene Figure 2.3, Metabolic pathways of benzo[a]pyrene (B[a]P) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) - The Health Consequences of Involuntary Exposure to Tobacco Smoke Frontiers | Benzo(a)pyrene and cardiovascular

Six animals with normal thyroid profiles were randomly assigned to each experimental group according to G-Power analysis

Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists

Downregulation of glyoxalase system does not result in MG accumulation Lower activity of the glyoxylate system through ROS deactivation and/or hypoxia-driven downregulation would be expected to lead to local MG accumulation in tumor tissue, especially since solid tumors are known to exhibit a high level of glycolytic dependency 56

For patients dealing with complex chronic illnesses, the body's detoxification pathways are often sluggish or completely overwhelmed by the constant generation of inflammatory cytokines and cellular debris